Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Börjesson

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Protein Engineering|November 25, 2003
Effect of mutations involving charged residues on the stability of staphylococcal nuclease: a continuum electrostatics studyUlf Börjesson, Philippe H Hünenberger
Bioorganic & Medicinal Chemistry Letters|May 15, 2022
Surprising lipophilicity observations identify unexpected conformational effectsMatthew W D Perry, Ulf Börjesson, Antonios Nikitidis, et al.
Journal of Chemical Information and Modeling|May 13, 2009
ProSAR: a new methodology for combinatorial library designHongming Chen, Ulf Börjesson, Ola Engkvist, et al.
Elife|March 1, 2022
Chemogenetics defines a short-chain fatty acid receptor gut-brain axisNatasja Barki, Daniele Bolognini, Ulf Börjesson, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-METGavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
The Journal of Biological Chemistry|April 10, 2025
Mechanism and kinetics of turnover inhibitors of nicotinamide N-methyl transferase in vitro and in vivoTomas Akerud, Claudia De Fusco, Peter Brandt, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2022
Discovery of a selective c-MET inhibitor with a novel binding modeGavin W Collie, Louise Barlind, Sana Bazzaz, et al.
Cell Death Discovery|March 4, 2020
Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibitionHugo Brito, Vanda Marques, Marta B Afonso, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 BindersPaolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.
RSC Medicinal Chemistry|November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment setSimon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Protein Engineering|November 25, 2003
Effect of mutations involving charged residues on the stability of staphylococcal nuclease: a continuum electrostatics studyUlf Börjesson, Philippe H Hünenberger
Bioorganic & Medicinal Chemistry Letters|May 15, 2022
Surprising lipophilicity observations identify unexpected conformational effectsMatthew W D Perry, Ulf Börjesson, Antonios Nikitidis, et al.
Journal of Chemical Information and Modeling|May 13, 2009
ProSAR: a new methodology for combinatorial library designHongming Chen, Ulf Börjesson, Ola Engkvist, et al.
Elife|March 1, 2022
Chemogenetics defines a short-chain fatty acid receptor gut-brain axisNatasja Barki, Daniele Bolognini, Ulf Börjesson, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-METGavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
The Journal of Biological Chemistry|April 10, 2025
Mechanism and kinetics of turnover inhibitors of nicotinamide N-methyl transferase in vitro and in vivoTomas Akerud, Claudia De Fusco, Peter Brandt, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2022
Discovery of a selective c-MET inhibitor with a novel binding modeGavin W Collie, Louise Barlind, Sana Bazzaz, et al.
Cell Death Discovery|March 4, 2020
Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibitionHugo Brito, Vanda Marques, Marta B Afonso, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 BindersPaolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.
RSC Medicinal Chemistry|November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment setSimon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
Pageof 3